Drug Pipeline

Vutrisiran Clinical Trials

Name: Vutrisiran clinical trials — 3 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Phase 3

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-05-15	NCT07223203 TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With…	Trial sites expanded: 4 -> 16 locations

Active Studies by Phase

Phase 3

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT07223203	TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With…	Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy	Recruiting
NCT04153149	HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With…	Transthyretin Amyloidosis (ATTR) With Cardiomyopathy	Active, Not Recruiting
NCT06679946	A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With…	Transthyretin Amyloidosis (ATTR) With Cardiomyopathy	Enrolling by Invitation

Sponsors Running Vutrisiran Trials

Alnylam Pharmaceuticals (3)

Disease Areas

Amyloidosis (3)

Get alerts when Vutrisiran trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.